LETROZOL NORDIC FUSION: Compound Profile
Letrozole is a non-steroidal aromatase inhibitor extensively examined in endocrinological research for its potent inhibitory effects on estrogen biosynthesis pathways. This third-generation aromatase inhibitor demonstrates exceptional selectivity for the CYP19A1 enzyme, making it an invaluable research tool for investigating estrogen-dependent cellular processes. The NORDIC FUSION formulation provides researchers with a reliable compound for studying hormonal modulation mechanisms in controlled laboratory environments. Investigators can explore letrozole’s role in examining steroidogenesis interruption and its downstream effects on estrogen-responsive tissue models. For comprehensive research chemical supplies, explore our full range at Stroid UK Shop where we maintain rigorous quality standards across all product categories.
Laboratory Applications
Research applications for letrozole span multiple areas of endocrine system investigation, particularly in studies examining estrogen receptor signalling pathways and hormonal feedback mechanisms. Scientists utilise this compound to evaluate aromatase enzyme kinetics and investigate the physiological consequences of estrogen depletion in various tissue culture models. The compound’s high potency enables precise dose-response studies in cellular models examining estrogen-dependent gene expression and proliferation patterns. Advanced research protocols incorporate letrozole to study compensatory hormonal responses and hypothalamic-pituitary-gonadal axis modulation. Researchers interested in expanding their studies may also examine compounds from our aromatase inhibitors collection alongside complementary research tools from our SARMs range and peptides catalogue for comprehensive hormonal pathway investigations.
Specification Data
| Parameter | Value |
|---|---|
| Chemical Name | 4,4′-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile |
| CAS Number | 112809-51-5 |
| Molecular Formula | C₁₇H₁₁N₅ |
| Molecular Weight | 285.30 g/mol |
| Classification | Non-steroidal aromatase inhibitor |
| Solubility | DMSO, ethanol (limited water solubility) |
| Storage Conditions | Room temperature, dry environment, protect from light |
| Stability | Stable under recommended storage conditions |
Research Compliance
This letrozole preparation is manufactured strictly for in-vitro research applications and laboratory investigations only. The product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure proper laboratory safety protocols are followed when handling this compound, including appropriate ventilation and personal protective equipment. All studies should comply with institutional research guidelines and applicable regulations governing research chemical use. This product is supplied exclusively for legitimate scientific research purposes conducted by qualified researchers in appropriate laboratory settings.
